Skip to main content
. 2018 Dec 7;21:e00297. doi: 10.1016/j.btre.2018.e00297

Table 3.

Antimicrobial activity of synthesized silver nanoparticles against Staphylococcus aureus (St. a); Bacillus cereus (B. c); Escherichia coli (Es. c); Pseudomonas aeruginosa (Ps. a); Candida albicans (C. a).

Concentration μg/mL Zone of inhibition (mm)
Ar-AgNP Gram-positive bacteria
Gram-negative bacteria
Yeast pathogen
St. a B. c Es. c Ps. a C. a
50 14 13 16 18
75 15 15 18 19
100 18 17 12 22 21